The Office of Management and Budget (OMB) released a 400-page document last week outlining proposed revisions to the administration of federal awards. The document proposes expanding agency authority to monitor awards from pre-application through closeout and increasing the influence of political appointees and the White House over award decisions. “The OMB’s proposed rule is an…
Three Ways AI and Automation Are Reshaping Drug Safety
As clinical trials expand globally, their complexity has intensified, with a recent study indicating average complexity scores have risen by more than 10 percentage points in the last decade. This growing intricacy, compounded by exponential data growth and rapidly evolving regulations, reveals the limitations of traditional, manual pharmacovigilance systems and the urgent need for innovation.…
Elsevier: 96% of researchers weigh genAI’s benefits and misinformation risks
While corporate researchers in the pharmaceutical, material, and chemical industries hail AI as a game-changer for accelerating knowledge discovery and transforming industries, they are not blind to its potential downsides, according to a new research study from Elsevier. This apprehension centers largely on AI’s capacity to fuel misinformation, a concern 96% of respondents shared. That’s…